Differential adhesion-inhibitory patterns of antibodies raised against two major variants of the NTS-DBL2X region of VAR2CSA

Vaccine

Volumn 31, Issue 41, 2013, Pages 4516-4522

  Doritchamou, Justin ^a,b,c   Bigey, Pascal ^d   Nielsen, Morten Agertoug ^e,f   Gnidehou, Sédami ^b   Ezinmegnon, Sem ^c   Burgain, Aurore ^d   Massougbodji, Achille ^c   Deloron, Philippe ^a,b   Salanti, Ali ^e,f   Ndam, Nicaise Tuikue ^a,b,c,g  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^c UNIVERSITY OF ABOMEY CALAVI   (Benin)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f University of Copenhagen   (Denmark)

^g UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Malaria; Plasmodium falciparum; Pregnancy; Vaccine; VAR2CSA

Indexed keywords

ERYTHROCYTE MEMBRANE PROTEIN 1; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG; VAR2CSA PROTEIN;

ADULT; ANTIBODY PRODUCTION; ARTICLE; DNA EXTRACTION; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; PARASITE ISOLATION; PHYLOGENY; PLASMODIUM FALCIPARUM; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF;

BOVINE SERUM ALBUMIN; BSA; CHONDROITIN SULFATE A; CHONDROITIN SULFATE PROTEOGLYCAN; CSA; CSPG; DBL; DIMORPHIC SEQUENCE MOTIF; DSM; DUFFY BINDING-LIKE; ID; IE; INTER-DOMAIN; INTERMITTENT PREVENTIVE TREATMENT DURING PREGNANCY; IPTP; MALARIA; MEDIAN FLUORESCENCE INTENSITY; MFI; N-TERMINAL SEQUENCE; NTS; PBS; PFALCIPARUM-INFECTED ERYTHROCYTES; PFEMP1; PHOSPHATE BUFFERED SALINE; PLACENTAL MALARIA; PLASMODIUM FALCIPARUM; PLASMODIUM FALCIPARUM ERYTHROCYTE MEMBRANE PROTEIN 1; PM; PREGNANCY; VACCINE; VAR2CSA;

ADULT; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CELL ADHESION; ERYTHROCYTES; FEMALE; HUMANS; PLASMODIUM FALCIPARUM; PREGNANCY; RABBITS; YOUNG ADULT;

EID: 84883600510     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.07.072     Document Type: Article

References (32)

1. Fried M., Duffy P.E. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 1996, 1502-1504. 5267.
2. Beeson J.G., Amin N., Kanjala M., Rogerson S.J. Selective accumulation of mature asexual stages of Plasmodium falciparum-infected erythrocytes in the placenta. Infect Immun 2002, 70:5412-5415.
3. Brabin B.J. An analysis of malaria in pregnancy in Africa. Bull World Health Organ 1983, 61:1005-1016.
4. Salanti A., Staalsoe T., Lavstsen T., Jensen A.T., Sowa M.P., Arnot D.E., et al. Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol Microbiol 2003, 49:179-191.
5. Hviid L. The case for PfEMP1-based vaccines to protect pregnant women against Plasmodium falciparum malaria. Expert Rev Vaccines 2011, 10:1405-1414.
6. Viebig N.K., Gamain B., Scheidig C., Lépolard C., Przyborski J., Lanzer M., et al. A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A. EMBO Rep 2005, 6:775-781.
7. Tuikue Ndam N.G., Salanti A., Bertin G., Dahlbäck M., Fievet N., Turner L., et al. High level of var2csa transcription by Plasmodium falciparum isolated from the placenta. J Infect Dis 2005, 192:331-335.
8. Duffy M.F., Caragounis A., Noviyanti R., Kyriacou H.M., Choong E.K., Boysen K., et al. Transcribed var genes associated with placental malaria in Malawian women. Infect Immun 2006, 74:4875-4883.
9. Magistrado P., Salanti A., TuikueNdamN.G.Mwakalinga S.B., Resende M., Dahlback M., et al. VAR2CSA expression on the surface of placenta-derived Plasmodium falciparum-infected erythrocytes. J Infect Dis 2008, 198:1071-1074.
10. Salanti A., Dahlback M., Turner L., Nielsen M.A., Barfod L., Magistrado P., et al. Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. J Exp Med 2004, 200:1197-1203.
11. Tuikue Ndam N.G., Salanti A., Le-Hesran J.Y., Cottrell G., Fievet N., Turner L., et al. Dynamics of anti-VAR2CSA immunoglobulin G response in a cohort of senegalese pregnant women. J Infect Dis 2006, 193:713-720.
12. Tutterrow Y.L., Avril M., Singh K., Long C.A., Leke R.J., Sama G., et al. High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission. Infect Immun 2012, 80:1479-1490.
13. Nielsen M.A., Pinto V.V., Resende M., Dahlbäck M., Ditlev S.B., Theander T.G., et al. Induction of adhesion-inhibitory antibodies against placental Plasmodium falciparum parasites by using single domains of VAR2CSA. Infect Immun 2009, 77:2482-2487.
14. Dahlback M., Nielsen M.A., Salanti A. Can any lessons be learned from the ambiguous glycan binding of PfEMP1 domains. Trends Parasitol 2010, 26:230-235.
15. Khunrae P., Dahlback M., Nielsen M.A., Andersen G., Ditlev S.B., Resende M., et al. Full-length recombinant Plasmodium falciparum VAR2CSA binds specifically to CSPG and induces potent parasite adhesion-blocking antibodies. J Mol Biol 2010, 397:826-834.
16. Srivastava A., Gangnard S., Round A., Dechavanne S., Juillerat A., Raynal B., et al. Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSA. Proc Natl Acad Sci USA 2010, 107:4884-4889.
17. Smith J.D., Subramanian G., Gamain B., Baruch D.I., Miller L.H. Classification of adhesive domains in the Plasmodium falciparum erythrocyte membrane protein 1 family. Mol Biochem Parasitol 2000, 110:293-310.
18. Trimnell A.R., Kraemer S.M., Mukherjee S., Phippard D.J., Janes J.H., Flamoe E., et al. Global genetic diversity and evolution of var genes associated with placental and severe childhood malaria. Mol Biochem Parasitol 2006, 148:169-180.
19. Bockhorst J., Lu F., Janes J.H., Keebler J., Gamain B., Awadalla P., et al. Structural polymorphism and diversifying selection on the pregnancy malaria vaccine candidate VAR2CSA. Mol Biochem Parasitol 2007, 155:103-112.
20. Bigey P., Gnidehou S., Dorichamou J., Quiviger M., Viwami F., Couturier A., et al. The NTS-DBL2X region of VAR2CSA induces cross-reactive antibodies that inhibit adhesion of several Plasmodium falciparum isolates to chondroitin-sulfate A. J Infect Dis 2011, 204:1125-1133.
21. Bordbar B., Tuikue-Ndam N., Bigey P., Doritchamou J., Scherman D., Deloron P. Identification of Id1-DBL2X of VAR2CSA as a key domain inducing highly inhibitory and cross-reactive antibodies. Vaccine 2012, 30:1343-1348.
22. Srivastava A., Gangnard S., Dechavanne S., Amirat F., Lewit Bentley A., et al. Var2CSA minimal CSA-binding region is located within the N-terminal region. PLoS one 2011, 6:e20270.
23. Dahlback M., Jorgensen L.M., Nielsen M.A., Clausen T.M., Ditlev S.B., Resende M., et al. The chondroitin sulfate A-binding site of the VAR2CSA protein involves multiple N-terminal domains. J Biol Chem 2011, 286:15908-15917.
24. Clausen T.M., Christoffersen S., Dahlback M., Langkilde A.E., Jensen K.E., Resende M., et al. Structural and functional insight into how the Plasmodium falciparum VAR2CSA protein mediates binding to chondroitin sulfate A in placental malaria. J Biol Chem 2012, 287:23332-23345.
25. Sander A.F., Salanti A., Lavstsen T., Nielsen M.A., Magistrado P., Lusingu J., et al. Multiple var2csa-type PfEMP1 genes located at different chromosomal loci occur in many Plasmodium falciparum isolates. PLoS one 2009, 4:e6667.
26. Akogbeto M., Modiano D., Bosman A. Malaria transmission in the lagoon area of Cotonou, Benin. Parassitologia 1992, 34:147-154.
27. Trager W., Jensen J.B. Human malaria parasites in continuous culture. Science 1976, 193:673-675.
28. Haase R.N., Megnekou R., Lundquist M., Ofori M.F., Hviid L., Staalsoe T. Plasmodium falciparum parasites expressing pregnancy-specific variant surface antigens adhere strongly to the choriocarcinoma cell line BeWo. Infect Immun 2006, 74:3035-3038.
29. Snounou G., Zhu X., Siripoon N., Jarra W., Thaithong S., Brown K.N., et al. Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Trans R Soc Trop Med Hyg 1999, 93:369-374.
30. Trollet C., Pereira Y., Burgain A., Litzler E., Mezrahi M., Seguin J., et al. Generation of high-titer neutralizing antibodies against botulinum toxins A, B, and E by DNA electrotransfer. Infect Immun 2009, 77:2221-2229.
31. Magistrado P.A., Minja D., Doritchamou J., Ndam N.T., John D., Schmiegelow C., et al. High efficacy of anti DBL4varepsilon-VAR2CSA antibodies in inhibition of CSA-binding Plasmodium falciparum-infected erythrocytes from pregnant women. Vaccine 2011, 29:437-443.
32. Doritchamou J., Bertin G., Moussiliou A., Bigey P., Viwami F., Ezinmegnon S., et al. First trimester Plasmodium falciparum infections display a typical 'placental' phenotype. J Infect Dis 2012, 206:1911-1919.